Evidence map›Paper›PMID 34869067›Full record

ArticleFrontiers in cellular and infection microbiology2021

Can the SARS-CoV-2 Spike Protein Bind Integrins Independent of the RGD Sequence?

Christopher A Beaudoin, Samir W Hamaia, Christopher L-H Huang, Tom L Blundell, Antony P Jackson

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Integrin αProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  9. Article
  10. Targeting integrin pathways: mechanisms and advances in therapy.Signal transduction and targeted therapy · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Integrins as Therapeutic Targets for SARS-CoV-2.Frontiers in cellular and infection microbiology · 2022
    Article
  16. SARS-CoV-2 Spike Protein Unlikely to Bind to IntegrinsFrontiers in molecular biosciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Christopher A BeaudoinDepartment of Biochemistry, Sanger Building, University of Cambridge, Cambridge, United Kingdom.
Samir W HamaiaDepartment of Biochemistry, Hopkins Building, University of Cambridge, Cambridge, United Kingdom.
Christopher L-H HuangDepartment of Biochemistry, Hopkins Building, University of Cambridge, Cambridge, United Kingdom.
Tom L BlundellDepartment of Biochemistry, Sanger Building, University of Cambridge, Cambridge, United Kingdom.
Antony P JacksonDepartment of Biochemistry, Hopkins Building, University of Cambridge, Cambridge, United Kingdom.
University of Cambridge · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

The RGD motif in the Severe Acute Syndrome Coronavirus 2 (SARS-CoV-2) spike protein has been predicted to bind RGD-recognizing integrins. Recent studies have shown that the spike protein does, indeed, interact with α

Indexed as

COVID-19Spike Glycoprotein, CoronavirusCell LineHumansIntegrinsMembrane GlycoproteinsOligopeptidesPeptidyl-Dipeptidase ASARS-CoV-2Viral Envelope ProteinsIntegrinsMembrane GlycoproteinsOligopeptidesPeptidyl-Dipeptidase ASpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Viral Envelope Proteinsbioinformaticsintegrinintegrin-binding motifRGDSARS-CoV-2SARS-CoV-2 spike protein

Identifiers

PMID34869067
PMCPMC8637727
OpenAlexW3213419463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.